Carmignac Gestion »

Cerevel Therapeutics Hldng I shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.0M 142k 42.27

More positions owned by Carmignac Gestion

Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
General Electric (GE)
Micron Technology (MU)
Taiwan Semiconductor Sponsored Ads (TSM)
Baxter International (BAX)
Metropcs Communications (TMUS)
S&p Global (SPGI)
Intercontinental Exchange (ICE)
Estee Lauder Companies Cl A (EL)

View all positions for Carmignac Gestion

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I